Working… Menu

Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03158129
Recruitment Status : Recruiting
First Posted : May 17, 2017
Last Update Posted : April 28, 2021
Information provided by (Responsible Party):
M.D. Anderson Cancer Center